Showing results (351-360 of 773) with videos related to
Sort By:
Pageof 78
Journal of the American Academy of Dermatology|October 15, 2017
Spectrum of orocutaneous disease associations: Genodermatoses and inflammatory conditionsElizabeth G Wilder, Jillian Frieder, Suraj Sulhan, et al.Human Molecular Genetics|August 3, 2011
Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAomeCailin E Joyce, Xiang Zhou, Jing Xia, et al.Allergy|November 30, 2022
Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advancesAllen Kaplan, Mark Lebwohl, Ana M Giménez-Arnau, et al.The British Journal of Dermatology|May 14, 2025
Efficacy and safety of tildrakizumab in patients with early- vs late-onset psoriasisApril W Armstrong, Andrew Blauvelt, Mark Lebwohl, et al.Journal of the American Academy of Dermatology|June 14, 2002
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar linesJ Alastair Carruthers, Nicholas J Lowe, M Alan Menter, et al.American Journal of Clinical Dermatology|September 8, 2019
Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II StudyMark G Lebwohl, Andrew Blauvelt, Alan Menter, et al.Journal of the American Academy of Dermatology|March 12, 2010
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trialAlan Menter, Matthias Augustin, James Signorovitch, et al.Journal of the American Academy of Dermatology|January 3, 2015
Efficacy and safety of brodalumab in subpopulations of patients with difficult-to-treat moderate-to-severe plaque psoriasisKim Papp, Alan Menter, Bruce Strober, et al.The New England Journal of Medicine|October 1, 2015
Phase 3 Studies Comparing Brodalumab with Ustekinumab in PsoriasisMark Lebwohl, Bruce Strober, Alan Menter, et al.Journal of the American Academy of Dermatology|August 21, 2007
Are patients with psoriasis undertreated? Results of National Psoriasis Foundation surveyElizabeth J Horn, Kathleen M Fox, Vaishali Patel, et al.Pageof 78